Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
68 participants
INTERVENTIONAL
2005-12-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smokers-nicotine
Smokers who were treated with nicotine
nicotine patch
nicotine patch (0,5,10 or 15mg/day) applied to smokers
Nonsmokers-nicotine
Nonsmokers who were treated with nicotine
nicotine patch
nicotine patch (0,5,10,or 15mg/day) applied to nonsmokers
Smokers-placebo
Smokers who were treated with placebo
placebo
placebo patch applied to smokers
Nonsmokers-placebo
Nonsmokers who were treated with placebo
placebo
placebo patch applied to nonsmokers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nicotine patch
nicotine patch (0,5,10 or 15mg/day) applied to smokers
nicotine patch
nicotine patch (0,5,10,or 15mg/day) applied to nonsmokers
placebo
placebo patch applied to smokers
placebo
placebo patch applied to nonsmokers
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Former smoker
* Pregnant
* Nursing
* Asthma
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamela Flood, MD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University Irving Medical Center / New York Presbyterian
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Olson LC, Hong D, Conell-Price JS, Cheng S, Flood P. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study. Anesth Analg. 2009 Dec;109(6):1987-91. doi: 10.1213/ANE.0b013e3181bd1612.
Hong D, Conell-Price J, Cheng S, Flood P. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study. Anesth Analg. 2008 Sep;107(3):1005-10. doi: 10.1213/ane.0b013e318163204f.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAB5945
Identifier Type: -
Identifier Source: org_study_id